Agentes antileucotrienos comparados con corticosteroides inhalados para el tratamiento del asma recurrente y crónica en pacientes adultos y niños
Información
- DOI:
- https://doi.org/10.1002/14651858.CD002314.pub3Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 16 mayo 2012see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Vías respiratorias
- Copyright:
-
- Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Dr Bhupendrasinh Chauhan reviewed the literature search from 2003 to December 2010, identified and reviewed all citations for relevance, reviewed all included trials for methodology and data extraction, verified all references, description of studies and data entry, analysed and interpreted results of the meta‐analysis, manuscript writing.
Prof Francine Ducharme conceived the protocol, requested the literature search, identified and contacted the corresponding authors and/or the pharmaceutical companies to solicit their collaboration in this review and in the identification of other possibly relevant trials, created the methodology and data extraction forms, reviewed all citations for relevance with research assistants, reviewed all included trials for methodology and data extraction, corresponded with authors or pharmaceutical companies to verify methodology and data extraction, verified all references, description of studies and data entry, analysed and interpreted results of the meta‐analysis.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Francine Ducharme is supported by a National Researcher Award from the Fonds de la Santé du Québec, Canada.
-
Bhupendrasinh Chauhan, Canada.
received a postdoctoral scholarship from Canadian Institute of Health Research, Canada
Declarations of interest
Bhupendrasinh Chauhan ‐ none known.
Prof. Francine Ducharme has received travel support, research funds and fees for speaking from Glaxo SmithKline, Novartis, Nycomed, and Merck Frosst Inc.
Acknowledgements
We wish to thank Franco Di Salvio and Giselle Hicks for their participation in the assessment of methodology and data extraction, and diligent data entry in 2003 update. We are indebted to the following individuals who replied to our request for confirmation of methodology and data extraction, and graciously provided additional data whenever possible: Christopher Miller and Susan Shaffer from Astra‐Zeneca, USA in 2003; Ian Naya and Roger Metcalf for Astra‐Zeneca, Sweden; Theodore F Reiss and GP Noonan from Merck Frosst, USA; Frank Kanniess from the Pulmonary Research Institute, Germany; and Graziano Riccioni, Italy, Sept‐Oct 2003 .
We are indebted to the Cochrane Airways Review Group, namely Toby Lasserson, Karen Blackhall, Dr Emma Welsh and Elizabeth Stovold for the literature search and ongoing support, and Paul Jones and Christopher Cates for their constructive comments. A special thanks to Mrs Anne James from the Consumer group for writing the original synopsis.
Version history
| Published | Title | Stage | Authors | Version |
| 2012 May 16 | Anti‐leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children | Review | Bhupendrasinh F Chauhan, Francine M Ducharme | |
| 2004 Jan 26 | Anti‐leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children | Review | Francine Ducharme, Franco di Salvio | |
| 2002 Jan 15 | Anti‐leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children | Review | FM Ducharme, GC Hicks | |
Differences between protocol and review
We revised the protocol to take account of the new methods in the Cochrane Handbook for Systematic Reviews of Interventions.
-
Updated the Cochrane Collaboration's 'Risk of bias' tool to include six domains
